ClinVar Miner

Submissions for variant NM_001540.5(HSPB1):c.250G>A (p.Gly84Arg) (rs770272088)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV000778833 SCV000915225 likely pathogenic HSPB1-Related Disorders 2017-09-05 criteria provided, single submitter clinical testing The HSPB1 c.250G>A (p.Gly84Arg) missense variant has been reported in two studies and found in a total of three affected individuals, including in a homozygous state in two siblings with distal hereditary motor neuropathy (dHMN) and in a presumed heterozygous state in one individual with Charcot-Marie-Tooth, type 2 (CMT2) (Manganelli et al. 2014; Ho et al. 2017). This variant was also identified in a heterozygous state in both presumably unaffected parents of the homozygous siblings. A second variant at the same nucleotide position, c.250G>C, also results in a p.Gly84Arg amino acid change and has been reported in a total of five individuals, including in a homozygous state in one individual with early onset CMT2, in a heterozygous state in two individuals with dHMN, and in a heterozygous state in the parents of the homozygous individual, both of whom displayed sub-clinical features, (James et al. 2008; Houlden et al. 2008; Fischer et al. 2012). Control data are unavailable for this variant, which is reported at a frequency of 0.000017 in the European (non-Finnish) population of the Genome Aggregation Database, but this is based on one allele in a region of good sequencing coverage so it is presumed to be rare. Expression of the p.Gly84Arg variant in HeLa cells led to abnormal protein aggregation (James et al. 2008), and protein interaction studies revealed that while the p.Gly84Arg variant does not affect neurofilament assembly, it does impact mobility and accessibility of the N-terminal domain, which modifies interdimer contacts in HspB1 oligomers (Nefedova et al. 2013; Nefedova et al. 2017). Based on the collective evidence, the c.250G>A (p.Gly84Arg) variant is classified as likely pathogenic for HSPB1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV001268008 SCV001446582 pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
Inherited Neuropathy Consortium RCV000789964 SCV000929350 uncertain significance Charcot-Marie-Tooth disease no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.